Coronary Microvascular Disease: Clinical Trials

44 trials for Coronary Microvascular Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 9 recruiting, 8 unknown, 6 active not recruiting. 16 Not applicable, 5 Phase 4, 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 6, Active not recruiting 4, Recruiting 2, Enrolling by invitation 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 45Not yet recruiting 2, Completed 1, Recruiting 1, Unknown 1
Phase 22Terminated 1, Unknown 1
Phase 11Recruiting 1
Phase 31Unknown 1

Follow Coronary Microvascular Disease: new trials by email Literature Review of Coronary Microvascular Disease trials Research Report on Coronary Microvascular Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
Coronary angiogram with coronary reactivity testing (CRT) - Myocardial Infarction, Coronary Microvascular Disease
Not yet recruitingMayo Clinic522027-01-012026-08-31
Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills
Compound Danshen Dripping Pills, Placebo - Coronary Microvascular Disease
Phase 4Not yet recruitingQilu Hospital of Shandong University4962026-10-012026-10-21
Coronary Sinus Reducer in Coronary Microvascular Disease
Coronary sinus reducer, Sham CSR procedure - Angina (Stable), Coronary Microvascular Disease
Not applicableEnrolling by invitationUMC Utrecht502025-11-202025-12-04
The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial
Coronary Artery Disease, Coronary Microvascular Disease
Enrolling by invitationUniversity of California, Los Angeles602025-08-132026-08-17
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
Brenzavvy (bexagliflozin), 20 mg Oral Tablet, Placebo - Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease
Phase 1RecruitingUniversity of Virginia1502025-07-152026-09-09
Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)
A-FLUX Reducer System - Coronary Microvascular Dysfunction, Coronary Microvascular Disease
Not applicableActive not recruitingVahatiCor, Inc.302025-06-182026-08-26
Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease
Kuangxiong Aerosol, Placebo Drug - Coronary Microvascular Disease
Phase 4Not yet recruitingChina-Japan Friendship Hospital5282025-04-012025-04-11
An Observational Study of Coronary Microvascular Disease of China
Coronary Microvascular Disease
RecruitingHenan Institute of Cardiovascular Epidemiology5002024-11-112025-08-20
Impact of Exercise Training on Ischemia With Non-Obstructive Coronary Arteries (INOCA): The ExINOCA Study
Exercise training - Coronary Microvascular Disease, CMD
Not applicableRecruitingBispebjerg Hospital1002024-11-012025-02-21
Insulin Resistance and Coronary Microvascular Dysfunction in Patients With Myocardial Ischemia and Non-obstructive Coronary Artery Disease
Thermodilution based assessment of coronary microcirculation, Hyperinsulinemic-euglycemic Clamp test - Coronary Microvascular Dysfunction, Coronary Microvascular Disease
Not applicableActive not recruitingAzienda Ospedaliera Universitaria Integrata Verona402024-06-242026-10-27
MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
CardioFlux - Ischemic Heart Disease, Coronary Microvascular Disease
CompletedGenetesis Inc.1362024-06-032025-07-10
MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR
CardioFlux Magnetocardiography - Ischemic Heart Disease, Coronary Microvascular Disease
CompletedGenetesis Inc.482023-12-202024-05-31
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Qishenyiqi dripping pills 1 bag, three times a day, Placebo 1 bag, three times a day - Coronary Microvascular Disease
Phase 4RecruitingQilu Hospital of Shandong University1622023-11-082024-11-21
Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition
Coronary physiology assessment - Coronary Microvascular Disease, Coronary Vasospasm
RecruitingJohannes Gutenberg University Mainz10002023-09-302024-11-01
Coronary Flow During Rapid Heart Rates
Pressure and flow measurement during simulated VT - Ventricular Tachycardia, Coronary Artery Disease
RecruitingImperial College London702023-08-012026-03-27
Exercise and Coronary Microvascular Disease
Cardiac rehabilitation - Coronary Microvascular Disease
Not applicableActive not recruitingCoreAalst BV2042023-07-312026-01-20
Serial PET MPI in Patients Undergoing Cancer Treatment
Cancer, Chemotherapeutic Toxicity
Enrolling by invitationUniversity of California, Los Angeles602023-06-012025-08-06
A Clinical Study of Fundus OCTA for the Identification of CMD
CaIMR - Coronary Microvascular Disease
RecruitingPeking University First Hospital4002023-03-012025-08-12
A Non-invasive Index of Microciculatory Resistance
CCTA, CT-MPI, DSA, FFR - Coronary Microvascular Disease, Coronary Artery Disease
Not applicableCompletedFirst People's Hospital of Hangzhou2952022-12-152025-06-04
Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor
Intra coronary rapid-exchange iKOs microcatheter intervention - Coronary Artery Disease, Coronary Stenosis
Not applicableCompletedQueen Mary University of London102022-12-142024-04-30

Showing 20 of 44. Sign in to see all of them.

Narrower conditions

Microvascular Angina (44)  ·  Angina Pectoris (9)  ·  Coronary Artery Disease (7)  ·  Myocardial Ischemia (7)  ·  Myocardial Infarction (5)  ·  Angina, Stable (2)  ·  Heart Failure (2)  ·  Anxiety Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Chest Pain (1)  ·  Coitus (1)  ·  Coronary Stenosis (1)  ·  Coronary Vasospasm (1)  ·  Factor XIII Deficiency (1)  ·  Hypertension (1)

Broader conditions

Heart Diseases (44)  ·  Vascular Diseases (44)  ·  Cardiovascular Diseases (43)  ·  Myocardial Ischemia (37)  ·  Angina Pectoris (35)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Neurologic Manifestations (10)  ·  Pain (10)  ·  Signs and Symptoms (10)  ·  Chest Pain (9)  ·  Coronary Disease (8)  ·  Arterial Occlusive Diseases (7)  ·  Arteriosclerosis (7)  ·  Pathologic Processes (7)  ·  Infarction (6)

Interventions

Adenosine (2)  ·  Caloric Restriction (1)  ·  Cardiac Rehabilitation (1)  ·  Cardiotonic Agents (1)  ·  Contrast Media (1)  ·  Coronary Angiography (1)  ·  Diet (1)  ·  Dosage Forms (1)  ·  Endurance Training (1)  ·  Exercise (1)  ·  Heparin (1)  ·  Laser-Doppler Flowmetry (1)  ·  Magnetic Resonance Imaging (1)  ·  Myocardial Perfusion Imaging (1)  ·  Pressure (1)

Sponsors

Qilu Hospital of Shandong University (4)  ·  Bispebjerg Hospital (2)  ·  CoreAalst BV (2)  ·  Genetesis Inc. (2)  ·  Johannes Gutenberg University Mainz (2)  ·  Queen Mary University of London (2)  ·  University Hospital, Grenoble (2)  ·  University of California, Los Angeles (2)  ·  University of Virginia (2)  ·  AHEPA University Hospital (1)  ·  Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Cedars-Sinai Medical Center (1)  ·  China-Japan Friendship Hospital (1)  ·  First People's Hospital of Hangzhou (1)  ·  Fundación EPIC (1)

Countries

United States (10)  ·  China (8)  ·  Spain (5)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Denmark (3)  ·  Germany (3)  ·  Netherlands (3)  ·  France (2)  ·  Italy (2)  ·  Brazil (1)  ·  Greece (1)  ·  Poland (1)  ·  Serbia (1)  ·  South Korea (1)

Top investigators

Eva Prescott, MD, DMSc (2)  ·  Anthony Mathur (1)  ·  Bo Zheng, Dr (1)  ·  Claire Raphael, MBBS, PhD. (1)  ·  Daniel Jones, MBBS, PhD (1)  ·  Georgios Giannakoulas, MD, PhD (1)  ·  Gilles Barone-Rochette (1)  ·  Jamieson Bourque, BA,MD,MHS (1)  ·  Jean-Paul Van Vooren, MD, PhD (1)  ·  Joo Myung Lee, MD, MPH, PhD (1)  ·  Josep Gomez Lara, MD PhD (1)  ·  Kristen K Buck, MD (1)  ·  Lijun Guo (1)  ·  Nashwa Abdulsalam, MD (1)  ·  Nathaniel Smilowitz, MD (1)

Results publications

PMID 10675425, PMID 11788217, PMID 11991214, PMID 12147179, PMID 12914662, PMID 13394341, PMID 15007010, PMID 15020531, PMID 15671433, PMID 16368303, PMID 16458167, PMID 16923752, PMID 16988070, PMID 17430682, PMID 18370439, PMID 19231324, PMID 19351944, PMID 19433695, PMID 19712795, PMID 19833255, PMID 19878986, PMID 20220183, PMID 20579539, PMID 21105792, PMID 21450596, PMID 21861950, PMID 21911339, PMID 21982660, PMID 22007073, PMID 22322081, PMID 22952138, PMID 22958953, PMID 23281541, PMID 23432189, PMID 23558043, PMID 23636227, PMID 24026779, PMID 24071763, PMID 24252596, PMID 24563437, PMID 24655692, PMID 25082954, PMID 25110069, PMID 25663817, PMID 25802037, PMID 27068634, PMID 33640311, PMID 34066713, PMID 34593129, PMID 34620412

NIH funding

K23HL119620 (1), R01HL124649 (1)